On ECHEMI
Home > Drugs > Polio
Polio
Poliomyelitis (hereinafter referred to as polio) is an acute infectious disease caused by the polio virus. Most cases are latent infection and no paralysis during epidemics. The incidence rate in children is higher than that in adults. Before the universal vaccination, infants and young children were more likely to be sick, so it was called infantile paralysis. The main clinical manifestations are fever, sore throat and limb pain. Some patients may develop flaccid paralysis. The main lesions are in the gray matter of the spinal cord, and those with severe damage may have paralysis sequelae. Since the widespread use of vaccines to prevent this disease in the late 1950s, its incidence has dropped significantly. After smallpox was eradicated in the 1970s, polio has been set as the next target to be eradicated by the end of this century.
  • Site of disease:

    spinal cord
  • Infectious :

    Contagious
  • Frequent population:

    child
  • Related symptoms:

    Fever sore throat limb disorder paralysis quadriplegia
Related Drugs
Dibazole Tablets
Indication: Mild hypertension, cerebral vasospasm, gastrointestinal smooth muscle spasm, sequelae of poliomyelitis, peripheral facial nerve paralysis. It can also be used for post-pregnancy hypertension syndrome.
Manufacturer:

Yunpeng Pharmaceutical Group Co., Ltd.

Dibazole Tablets
Indication: Mild hypertension, cerebral vasospasm, gastrointestinal smooth muscle spasm, sequelae of poliomyelitis, peripheral facial nerve paralysis. It can also be used for post-pregnancy hypertension syndrome.
Manufacturer:

Sichuan Deyuan Pharmaceutical Group Co., Ltd.

Monophylline nitrate injection
Indication: For sequelae of poliomyelitis and facial nerve paralysis.
Acetylglutamine for injection
Indication: It is used for coma caused by brain trauma, coma caused by neurosurgery, hepatic coma, hemiplegia and high paraplegia, sequelae of polio, neuralgia and low back pain, etc.
Manufacturer:

Changchun HaiYue Pharmaceutical Limited By Share Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.